MALATO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 3.616
EU - Europa 2.776
AS - Asia 1.928
SA - Sud America 280
Continente sconosciuto - Info sul continente non disponibili 63
AF - Africa 53
OC - Oceania 2
Totale 8.718
Nazione #
US - Stati Uniti d'America 3.561
SG - Singapore 696
IT - Italia 664
CN - Cina 532
RU - Federazione Russa 509
DE - Germania 391
FI - Finlandia 340
UA - Ucraina 285
BR - Brasile 209
HK - Hong Kong 188
VN - Vietnam 171
GB - Regno Unito 120
PL - Polonia 102
IE - Irlanda 94
SE - Svezia 91
FR - Francia 80
JP - Giappone 78
KR - Corea 51
IN - India 49
BD - Bangladesh 32
BE - Belgio 32
CA - Canada 24
AR - Argentina 23
TR - Turchia 23
IQ - Iraq 20
MX - Messico 16
CI - Costa d'Avorio 15
ZA - Sudafrica 14
NL - Olanda 12
RO - Romania 12
UZ - Uzbekistan 12
VE - Venezuela 12
AT - Austria 11
IR - Iran 11
EC - Ecuador 10
ID - Indonesia 10
ES - Italia 9
MA - Marocco 9
PK - Pakistan 8
PY - Paraguay 8
CL - Cile 7
CO - Colombia 7
SA - Arabia Saudita 6
CR - Costa Rica 5
EU - Europa 4
GR - Grecia 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
MY - Malesia 4
PH - Filippine 4
TH - Thailandia 4
AL - Albania 3
BG - Bulgaria 3
CH - Svizzera 3
DZ - Algeria 3
EG - Egitto 3
QA - Qatar 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
HN - Honduras 2
JO - Giordania 2
MD - Moldavia 2
NP - Nepal 2
RS - Serbia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
MM - Myanmar 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 8.659
Città #
Ashburn 485
Singapore 465
Fairfield 261
Chandler 244
San Jose 232
Woodbridge 182
Hong Kong 180
Ann Arbor 160
Wilmington 159
Jacksonville 152
Houston 136
Palermo 119
Seattle 105
Dublin 93
Frankfurt am Main 90
Zgierz 89
Cambridge 88
Beijing 86
Moscow 79
Tokyo 77
Medford 68
Nanjing 66
Santa Clara 60
Ho Chi Minh City 58
Des Moines 54
New York 54
Boardman 52
Los Angeles 49
Princeton 45
Dearborn 42
Hanoi 42
Hefei 38
Tulsa 38
Altamura 34
Council Bluffs 33
The Dalles 33
Lauterbourg 31
Brussels 30
Helsinki 26
Lawrence 26
Orem 25
Dallas 22
São Paulo 22
Milan 20
Nanchang 20
Shenyang 20
Tianjin 20
Buffalo 18
San Diego 18
Jinan 16
Regensburg 16
Stockholm 16
Abidjan 15
Bremen 14
Changsha 14
Seongnam 14
Chicago 13
Kumar 13
Rome 13
Hebei 12
Izmir 12
Ludwigshafen am Rhein 12
Denver 11
Verona 11
Zhengzhou 11
Ningbo 10
Phoenix 10
San Mateo 10
Amsterdam 9
Brooklyn 9
Columbus 9
Guangzhou 9
Jiaxing 9
London 9
Napoli 9
Nuremberg 9
Shanghai 9
Tehran 9
Warsaw 9
Atlanta 8
Auburn Hills 8
Chennai 8
City of London 8
Poplar 8
Rio de Janeiro 8
Washington 8
Baghdad 7
Brasília 7
Haiphong 7
Hangzhou 7
Johannesburg 7
Kunming 7
Lanzhou 7
Turku 7
Cardiff 6
Haikou 6
Montreal 6
New Delhi 6
Newark 6
Springfield 6
Totale 5.036
Nome #
Curva da carico orale di metionina nella valutazione di pazienti affetti da patologia trombotica 662
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. 345
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 323
Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin. 265
Successful Treatment of Gastrointestinal Bleeding With Recombinant Factor VIIa After Kidney Transplantation in Patients With Pancytopenia. 248
Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management 241
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study 226
Peri-operative bridgning therapy with low molecular weight heparin in patients requiring interruption of long-term oral anticoagulant therapy 217
Recurrent venous thromboembolism complicated by heparin-induced thrombocytopenia as a first manifestation of an occult cancer: a case report. 217
The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. 216
Deferral of assessment of pulmonary embolism 215
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis 209
Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients 208
Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation 204
Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. 199
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression Ultrasonography (DACUS) study 198
PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY 197
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS 195
Gastrointestinal bleeding in patients with von Willebrand disease; how long we can wait for surgery? 190
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS Study 189
La profilassi chirurgica di pazienti con carenza congenita di FVII 188
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins 186
Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer. 173
The Persistance of Residual Vein Thrombosis, after an Episode of Deep Vein Thrombosis, and the Risk of New Overt Cancer and Cardiovascular Disease 172
Evaluation of patients with thrombotic stroke by methionine loading oral curve 168
THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE 164
Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. 163
The persistence of residual vein thrombosis, after an episode of deep vein thrombosis, and the risk of new overt cancer. 163
Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk 159
Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial 158
Uso del FVIIa ricombinante nell'emorragia gastrica post trapianto renale 157
ISAM: international study on anticoagulation management. The Italian experience 156
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis 156
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events. 156
Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia 156
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. 150
Successful treatment of acquired haemophilia with FEIBA and Retuximab 149
Residual vein thrombosis assessment establishes the otpimal duration of oral anticoagulants in patients with idiopathic or provoked deep vein thrombosis 142
Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus 136
Prognostic relevance of an asymptomatic venous thromboembolism in patients with cance 128
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial 122
Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT 121
Thrombophilia in women with unexplained fetal loss 116
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis. a randomized, controlled trial 115
Un caso di emorragia gastrica post-trapianto di rene 100
Totale 8.718
Categoria #
all - tutte 26.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022479 0 121 9 34 14 13 23 15 65 81 21 83
2022/2023670 67 107 16 92 83 107 36 52 68 2 31 9
2023/2024362 9 48 37 55 26 72 44 14 3 7 5 42
2024/2025699 23 29 5 81 41 16 44 32 48 72 114 194
2025/20263.111 224 104 167 273 338 450 329 288 191 564 74 109
2026/2027158 113 45 0 0 0 0 0 0 0 0 0 0
Totale 8.718